Novo Nordisk A/S (CPSE:NOVO B) agreed to acquire a 64.4% stake in Biocorp Production (ENXTPA:ALCOR) for 99.1 million on June 19, 2023. Under the terms, 35 per share in cash will be paid. Acquisition is subject to subject to customary regulatory approvals.
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |